Literature DB >> 6304177

Cyclic adenosine monophosphate effects on the myocardium: a man who blows hot and cold with one breath.

A M Katz.   

Abstract

Agents that increase cellular cyclic adenosine monophosphate (cyclic AMP) levels exert several effects on cardiac function. These include increases in heart rate and both the force of contraction and rate of relaxation. The latter effects, which might appear to be contradictory, actually represent essential components of the response needed to allow the heart to increase its stroke volume when heart rate is accelerated. This article reviews the mechanisms by which cyclic AMP exerts both contraction-promoting and relaxation-promoting effects in the integrated response of the heart to sympathetic stimulation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304177     DOI: 10.1016/s0735-1097(83)80387-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Calcium sensitisers.

Authors:  J A Lee; D G Allen
Journal:  BMJ       Date:  1990-03-03

2.  Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs.

Authors:  A Dorszewski; B Müller-Beckmann; L Kling; G Sponer
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 3.  Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.

Authors:  D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

Review 4.  [Alpha-adrenoceptors in the myocardium: incidence and functional significance].

Authors:  A Mügge
Journal:  Klin Wochenschr       Date:  1985-11-04

Review 5.  Intracellular calcium in heart failure.

Authors:  J P Morgan
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

6.  Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside.

Authors:  G Hasenfuss; C Holubarsch; H W Heiss; B Rattert; H Just
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

7.  Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations.

Authors:  G Hasenfuss; C Holubarsch; E M Blanchard; L A Mulieri; N R Alpert; H Just
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

8.  Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism.

Authors:  M Endoh
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

9.  Effects of alpha-adrenoceptor stimulation with phenylephrine in the presence of propranolol on force of contraction, slow inward current and cyclic AMP content in the bovine heart.

Authors:  R Brückner; H Scholz
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

Review 10.  Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.

Authors:  A Fitton; R N Brogden
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.